Evidence map›Paper›PMID 33407541›Full record

ArticleHuman resources for health2021

Preparing the healthcare workforce in South Africa for short-course rifampicin-resistant TB treatment: inter-professional training and task-sharing considerations.

Jason E Farley, Norbert Ndjeka, Khaya Mlandu, Kelly Lowensen, Keri Geiger, Yen Nguyen, Chakra Budhathoki, Paul D Stamper

Open access · goldAbstract read
In one paragraph

Article in Human resources for health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Jason E FarleyThe REACH Initiative, Johns Hopkins University School of Nursing, 855 N. Wolfe Street | Rangos Building Suite # 601, Mailbox #30, Baltimore, MD, 21205, United States of America. jfarley1@jhu.edu.ORCID 0000-0002-6896-0134
Norbert NdjekaNational Department of Health, CBD, Civitas Building, 222 Thabo Sehume St, Pretoria, 0001, South Africa.
Khaya MlanduThe REACH Initiative, Johns Hopkins University School of Nursing, 855 N. Wolfe Street | Rangos Building Suite # 601, Mailbox #30, Baltimore, MD, 21205, United States of America.
Kelly LowensenThe REACH Initiative, Johns Hopkins University School of Nursing, 855 N. Wolfe Street | Rangos Building Suite # 601, Mailbox #30, Baltimore, MD, 21205, United States of America.
Keri GeigerThe REACH Initiative, Johns Hopkins University School of Nursing, 855 N. Wolfe Street | Rangos Building Suite # 601, Mailbox #30, Baltimore, MD, 21205, United States of America.
Yen NguyenThe REACH Initiative, Johns Hopkins University School of Nursing, 855 N. Wolfe Street | Rangos Building Suite # 601, Mailbox #30, Baltimore, MD, 21205, United States of America.
Chakra BudhathokiThe REACH Initiative, Johns Hopkins University School of Nursing, 855 N. Wolfe Street | Rangos Building Suite # 601, Mailbox #30, Baltimore, MD, 21205, United States of America.
Paul D StamperThe REACH Initiative, Johns Hopkins University School of Nursing, 855 N. Wolfe Street | Rangos Building Suite # 601, Mailbox #30, Baltimore, MD, 21205, United States of America.
Johns Hopkins University · USDepartment of Health · ZA

Funding

A Nurse Case Management Intervention to Improve MDR-TB/HIV Coinfection OutcomesR01AI104488 · NIAID · JOHNS HOPKINS UNIVERSITY · PI FARLEY, JASON EDWARD · 2014 to 2019
$3.2M
NIAID NIH HHS R01 AI104488
6 · The paper itself

Abstract

backgroundTreatment for rifampicin-resistant Mycobacterium tuberculosis (RR-TB) is complex, however, shorter treatment, with newer antimicrobials are improving treatment outcomes. The South African National Department of Health (NDoH) recently accelerated the rollout of 9-month, all-oral, RR-TB short-course regimens. We sought to evaluate an inter-professional training program using pre-test and post-test performance of Professional Nurses (PNs), Advanced Practice Professional Nurses (APPNs) and Medical Officers (MOs) to inform: (a) training needs across cadres; (b) knowledge performance, by cadres; and (c) training differences in knowledge by nurse type.

methodsA 4-day didactic and case-based clinical decision support course for RR-TB regimens in South Africa (SA) was developed, reviewed and nationally accredited. Between February 2017 and July 2018, 12 training events were held. Clinicians who may initiate RR-TB treatment, specifically MOs and PN/APPNs with matched pre-post tests and demographic surveys were analyzed. Descriptive statistics are provided. Pre-post test evaluations included 25 evidence-based clinically related questions about RR-TB diagnosis, treatment, and care.

resultsParticipants (N = 842) participated in testing, and matched evaluations were received for 800 (95.0%) training participants. Demographic data were available for 793 (99.13%) participants, of whom 762 (96.1%) were MOs, or nurses, either PN or APPNs. Average correct response pre-test and post-test scores were 61.7% (range 7-24 correct responses) and 85.9% (range 12-25), respectively. Overall, 95.8% (730/762) of participants demonstrated improved knowledge. PNs improved on average 25% (6.22 points), whereas MOs improved 10% (2.89 points) with better mean test scores on both pre- and post-test (p < 0.000). APPNs performed the same as the MOs on post-test scores (p = NS).

conclusionsThe inter-professional training program in short-course RR-TB treatment improved knowledge for participants. MOs had significantly greater pre-test scores. Of the nurses, APPNs outperformed other PNs, and performed equally to MOs on post-test scores, suggesting this advanced cadre of nurses might be the most appropriate to initiate and monitor treatment in close collaboration with MOs. All cadres of nurse reported the need for additional clinical training and mentoring prior to managing such patients.

Indexed as

RifampinTuberculosis, Multidrug-ResistantDelivery of Health CareHumansSouth AfricaWorkforceRifampinClinicalMultidrug-resistantNurse practitionerPrimary health careRifampicin-resistantSouth AfricaTuberculosis

Identifiers

PMID33407541
PMCPMC7788975
OpenAlexW3111579081

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.